CORCEPT THERAPEUTICS INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $CORT in the last 7 days.
Lyon Joseph Douglas (See Remarks) sold 10,000 shares of CORCEPT THERAPEUTICS INC (CORT) at an average of $113.49 ($113.32–$114.12, $1.13M total) across 2 trades on 2026-09-14 under a Rule 10b5-1 trading plan.
WILSON JAMES N sold 10,000 indirectly-held shares of CORCEPT THERAPEUTICS INC (CORT) at an average of $110.69 ($110.27–$111.70, $1.11M total) across 3 trades on 2026-09-15 under a Rule 10b5-1 trading plan.
S&P Dow Jones Indices announced changes to its major indices. Sandisk (SNDK) will join the S&P 100, replacing Colgate-Palmolive (CL). Other additions to the S&P 100 include Dell (DELL), Palo Alto Networks (PANW), and Arista Networks (ANET). The S&P 500 will add Bloom Energy (BE), Illumina (ILMN), and Everpure (P). Changes are effective before trading on Sept. 21, 2026.
Recent CORT coverage spans insider activity, sector analysis and market movers.
In the last 30 days, CORT insiders filed 22 SEC Form 4 transactions — no purchases and 22 sales ($31.0M). The most active reporter was Vieira Roberto Wandenkolk, President, Oncology, with 7 filings. 95% of those filings were made under pre-arranged Rule 10b5-1 plans.
Minor dilution of insider ownership; unlikely to move price materially.
Potential modest negative pressure as insider reduces stake.
Positive impact from index addition.
Insider sale by an officer may signal reduced confidence, potentially pressuring the stock lower.
The insider sale reduces insider ownership but is pre‑arranged, likely limiting immediate price impact.
AlphAI scores every news story that mentions CORT with an AI model for sentiment and relevance, and aggregates insider trades from CORCEPT THERAPEUTICS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Lyon Joseph Douglas (See Remarks) sold 10,000 shares of CORCEPT THERAPEUTICS INC (CORT) at an average of $113.49 ($113.32–$114.12, $1.13M total) across 2 trades on 2026-09-14 under a Rule 10b5-1 trading plan.
1 min readWILSON JAMES N sold 10,000 indirectly-held shares of CORCEPT THERAPEUTICS INC (CORT) at an average of $110.69 ($110.27–$111.70, $1.11M total) across 3 trades on 2026-09-15 under a Rule 10b5-1 trading plan.
1 min readS&P Dow Jones Indices announced changes to its major indices. Sandisk (SNDK) will join the S&P 100, replacing Colgate-Palmolive (CL). Other additions to the S&P 100 include Dell (DELL), Palo Alto Networks (PANW), and Arista Networks (ANET). The S&P 500 will add Bloom Energy (BE), Illumina (ILMN), and Everpure (P). Changes are effective before trading on Sept. 21, 2026.
2 min readMaduck Sean (See Remarks) sold 25,000 shares of CORCEPT THERAPEUTICS INC (CORT) at an average of $114.43 ($113.94–$115.61, $2.86M total) across 3 trades on 2026-09-01 under a Rule 10b5-1 trading plan.
1 min readVieira Roberto Wandenkolk (President, Oncology) sold 58,333 shares of CORCEPT THERAPEUTICS INC (CORT) at an average of $110.76 ($109.35–$115.44, $6.46M total) across 7 trades on 2026-09-02 under a Rule 10b5-1 trading plan.
1 min readPark Kimberly sold 26,685 shares of CORCEPT THERAPEUTICS INC (CORT) at $122.55 ($3.27M total) on 2026-08-26.
1 min readMaduck Sean (See Remarks) sold 30,955 shares of CORCEPT THERAPEUTICS INC (CORT) at an average of $125.58 ($125.47–$126.06, $3.89M total) across 2 trades on 2026-08-25 under a Rule 10b5-1 trading plan.
1 min readSeveral biotech stocks hit 52-week highs on August 21, 2026. Eloxx (ELOX) rose 16% to $23.40, reporting a Q2 net loss of $4.5M. argenX (ARGX) reached $1,058.69, with positive trial results for VYVGART. Corcept (CORT) hit $123.44, reporting $256M in Q2 revenue. Boundless Bio (BOLD) reached $3.02, initiating a first-in-human trial. Prelude (PRLD) peaked at $6.38, advancing JAK2V617F in Phase 1 trials.
3 min readMAHONEY DAVID L sold 103,606 indirectly-held shares of CORCEPT THERAPEUTICS INC (CORT) at an average of $118.25 ($117.47–$119.64, $12.25M total) across 4 trades on 2026-08-18 under a Rule 10b5-1 trading plan.
1 min readWILSON JAMES N sold 10,000 indirectly-held shares of CORCEPT THERAPEUTICS INC (CORT) at an average of $111.43 ($110.49–$112.64, $1.11M total) across 3 trades on 2026-08-14 under a Rule 10b5-1 trading plan.
1 min read